Minimally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview

imally invasive esophagectomy for esophageal cancer in the People's Republic of China: an overview Review (292) Total Article Views Authors: Zhu C, Jin K Published Date March 2013 Volume 2013:6 Pages 119 - 124 DOI: http://dx.doi.org/10.2147/OTT.S40667 Received: 24 November 2012 Accepted: 11 January 2013 Published: 04 March 2013 Chengchu Zhu,1 Ketao Jin2 1Department of Cardiothoracic Surgery, 2Department of Surgical Oncology, Taizhou Hospital, Wenzhou Medical College, Linhai, Zhejiang, People's Republic of China Abstract: Since its introduction in the People's Republic of China in 1992, minimally invasive esophagectomy (MIE) has shown the classical advantages of minimally invasive surgery over its open counterpart. Like all pioneers of the technique, cardiothoracic surgeons in the People's Republic of China claim that MIE has a lower risk of pulmonary infection, faster recovery, a shorter hospital stay, and a more rapid return to daily activities than open esophagectomy, while offering the same functional and oncologic results. There has been burgeoning interest in MIE in the People's Republic of China since 1995. The last decade has witnessed nationwide growth in the application of MIE and yielded a significant amount of scientific data in support of its clinical merits and advantages. However, no prospective randomized controlled trials have actually investigated the benefits of MIE in the People's Republic of China. Here we review the current data and state of the art MIE treatment for esophageal cancer in the People's Republic of China.